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Abstract
Background: The respiratory epithelium plays a central role in the inflammatory response in asthma and other
diseases. Methoxyphenolic compounds are purported to be effective anti-inflammatory agents, but their effects on
the airway epithelium have not been well characterized.
Methods: Human airway cells were stimulated with TNF-a in the presence or absence of 4-substituted
methoxyphenols and resveratrol. The expression of various cytokines was measured by qPCR, ELISAs, and protein
arrays. Reactive oxygen species (ROS) production was measured with a reactive fluorescent probe (3’,6’-diacetate-
2’,7’-dichlorofluorescein). Activation of NF-B was measured by nuclear translocation and phosphorylation.
Ribonuclear protein association with mRNA was assessed with a biotin-RNA affinity isolation assay.
Results: Multiple inflammatory mediators were inhibited by methoxyphenols, including: CCL2, CCL5, IL-6, IL-8,
ICAM-1, MIF, CXCL1, CXCL10, and Serpin E1. IC50 values were obtained for each compound that showed significant
anti-inflammatory activity: diapocynin (20.3 μM), resveratrol (42.7 μM), 2-methoxyhydroquinone (64.3 μM), apocynin
(146.6 μM), and 4-amino-2-methoxyphenol (410 μM). The anti-inflammatory activity did not correlate with inhibition
of reactive oxygen species production or NF-B activation. However, methoxyphenols inhibited binding of the
RNA-binding protein HuR to mRNA, indicating that they may act post-transcriptionally.
Conclusions: Methoxyphenols demonstrate anti-inflammatory activity in human airway cells. More potent
compounds that act via similar mechanisms may have therapeutic potential as novel anti-inflammatory agents.
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Background
The airway epithelium plays a crucial role in the patho-
genesis of asthma, chronic obstructive pulmonary dis-
ease, and other inflammatory lung diseases. By serving
as a key interface between the host and environment,
the airway participates in activation of innate immunity
and production of cytokines and other inflammatory
mediators in response to microbes, allergens, pollutants,
and other inflammatory stimuli [1,2]. As such, the air-
way epithelium is a prime target for anti-inflammatory
agents.
The production of cytokines from the airway epithe-
lium has been shown to play an important role in regu-
lating inflammation associated with respiratory diseases.
In response to various stimuli, the airway epithelium
produces numerous inflammatory mediators, such as
cytokines (TNF-a, IL-6, IL-8), chemokines (CCL2,
CCL5, CCL7), and other pro-inflammatory proteins
(ICAM-1) [3]. These mediators serve to activate and
attract leukocytes to the site of respiratory infection/
inflammation. Release of cytokines by leukocytes then
stimulates the airway epithelium to release more inflam-
matory mediators, thus making these cells central
players in both the induction as well as perpetuation of
the inflammatory response.
One of the major stimulants of the airway epithelium
is TNF-a, which induces the production of numerous
cytokines, chemokines, and other factors. TNF-a stimu-
lation can activate NF-B, MAP kinases, and induce the
production of ROS, which can act as second messengers
or oxidants of proteins and nucleic acids to potentiate
NF-B effects and inflammatory mediator production
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any medium, provided the original work is properly cited.[4,5]. TNF-a can also act post-transcriptionally to pro-
mote inflammation by increasing the stability of cyto-
kine mRNA [6]. We previously demonstrated that the
RNA-binding protein HuR has widespread pro-inflam-
matory effects on the airway epithelium, mediated by
the stabilization of cytokine mRNA after TNF-a treat-
ment [7]. Thus, TNF-a treatment of human airway cells
serves as an effective model to study regulation of the
inflammatory response via a number of mechanisms and
to test putative anti-inflammatory molecules.
There are currently few treatment options for inflam-
matory lung diseases such as severe asthma and COPD.
Methoxyphenolic compounds have been shown to have
anti-inflammatory action in leukocytes and endothelial
cells, and we have previously shown the anti-inflamma-
tory effects of apocynin (4-hydroxy-3-methoxy-aceto-
phenone) in these cells [8]. Apocynin, a naturally
occurring methoxyphenolic compound isolated from the
medicinal plant Picrorhiza kurroa, has been described as
a traditional medicinal treatment in numerous diseases,
including asthma [9]. Its mechanism of action is not
well understood, and in phagocytes it may act by inhi-
biting the translocation of the p47phox protein to the
cell membrane, inhibiting formation of the ROS-gener-
ating NADPH oxidase complex. The resulting inhibition
of ROS generation may play a crucial role in the attenu-
ating the inflammatory response. We previously demon-
strated that apocynin forms a dimer in the presence of
ROS and peroxidase, and this dimer, diapocynin, is the
active form of the drug [8]. It is thought the redox prop-
erties of the compound may promote oxidation of
cysteine residues to alter protein structure and/or phos-
porylation, which may underlie the inhibitory effect on
p47phox translocation [10]. Alternative models, particu-
larly in the endothelium, suggest that apocynin may act
as a free radical scavenger and its actions may not be
related to NADPH oxidase inhibition [11].
The effect of apocynin and other methoxyphenols
have not been well studied in epithelial cells. However,
as these cells play a central role in the inflammatory
response, we hypothesized that they are a target of the
anti-inflammatory effect of methoxyphenols. In this
study, we demonstrated the anti-inflammatory activity of
apocynin, diapocynin, resveratrol, and multiple 4-substi-
tuted methoxyphenolic compounds in TNF-a-stimu-
lated human airway cells. We showed that this effect is
not mediated though inhibition of ROS generation or
NF-B inhibition, indicating that these compounds act
via a distinct mechanism in airway epithelial cells. We
also demonstrate that apocynin inhibits HuR binding to
mRNA, suggesting a role in post-transcriptional regula-
tion. The significance of these findings is discussed
herein.
Methods
Cell culture and treatment conditions
The A549 and BEAS2B cell lines were obtained from
American Type Culture Collection (ATCC, Manassas,
VA), and cultured according to their recommended pro-
tocols. All cells were cultured at 37°C in humidified air
containing 5% CO2.I ns h o r t ,A 5 4 9c e l l sw e r em a i n -
tained in F-12 K media (ATCC) containing 10% fetal
bovine serum (Thermo Scientific, Rockford, IL), penicil-
lin (100 U/mL) (Mediatech Inc., Manassas, VA), and
streptomycin (100 mg/mL) (Mediatech). A549 cells were
used from passages 3 to 35. BEAS2B cells were main-
tained in F12/DMEM (Life Technologies/Invitrogen,
Frederick, MD) containing 10% FBS, penicillin (100
U/mL), and streptomycin (100 mg/mL). BEAS-2B cells
were used from passages 30-45. Normal human primary
bronchial epithelial cells were obtained from Lonza
(Walkersville, MD), and cultured in BEGM media per
manufacturer’s recommendations. All experiments were
performed between passages 4-6.
Tumor necrosis factor alpha (TNF-a)s o l u t i o nw a s
prepared by resuspending lyophilized protein (Becton,
Dickinson and Company, Franklin Lakes, NJ) in 0.1%
BSA (Bovine Serum Albumin) in ddH2O to give a work-
ing stock of 10 ng/uL. Cells were treated with 50 ng/mL
of TNF-a as indicated [12]. To assess the anti-inflam-
matory effects of various compounds (Figure 1A-I), cells
were treated with each compound concurrently with
TNF-a, in the presence or absence of 0.5 mg/ml Horse-
radish Peroxidase (HRP) (Sigma Aldrich, St Louis, MO)
and 25 μMH 2O2 (Sigma Aldrich, St Louis, MO). The
methoxyphenolic compound derivatives (Figure 1) were
prepared by dissolving/diluting each separately in 100%
ethanol to give stock solutions of 100 mM. Compounds
A, C-G and I were purchased from Sigma Aldrich and
compound B was purchased from Santa Cruz Biotech-
nology (Santa Cruz, CA). Compound H (Diapocynin)
was synthesized as previously described [13,14]. Diluent
(1% ethanol) was added to all untreated cells and TNF-
a-treated cells.
RNA isolation and real time PCR analysis of gene
expression
Total cellular RNA was isolated from cell cultures using
the TRIzol reagent method (Invitrogen). Cells were
treated for 24 hours with 50 ng/mL of TNF-a in the
presence of absence of 1 mM of each compound for the
specified time. The concentration and quality of the
isolated RNA was determined on an Ultrospec 3000
Spectrophotometer (Pharmacia Biotech). Cellular RNA
(2 μg) was reversed transcribed to form total cellular
cDNA via a High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). The cDNA levels of individual
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(Table 1) and a Sensimix SYBR green probe (Bioline) on
a MYiQ2 real time PCR (Bio-Rad, Hercules, CA). All
samples were run in triplicate and quantified using the
comparative cycle threshold (CT) method [15,16].
hCCL2, hCCL11 and GM-CSF ELISAss
Colorimetric human CCL2 (human chemokine (C-C
motif) ligand 2), CCL11, and GM-CSF (granulocyte-
macrophage colony stimulating factor) ELISAs (R&D
Systems, Minneapolis, MN) were used per the manufac-
turer protocol, with one modification: the supplied wash
buffer was replaced with 1X TBS-T (20 mM Tris pH
7.5, 150 mM NaCl, 0.1% Tween 20) to wash between
steps. Prior to treatment, the growth media was
removed from the adherent cells, PBS was used to wash
once, and fresh serum-free media was added. Cells were
mixed with TNF-a in the presence or absence of speci-
fic compounds or no treatment as described above for
24 hours. The media was collected, and secreted cyto-
k i n e sw e r em e a s u r e db yE L I S Aa ta1 : 4 0d i l u t i o ni n
ddH2O. The colorimetric absorbance was read at 450
nm using a GENios plate-reader (Tecan) running
Magellan 6.6 software. All experiments were performed
at least in triplicate. Data were analyzed using GraphPad
Prism 4.0 (GraphPad) to generate the concentration-
response curves and IC50 values were extrapolated.
Human cytokine array and analysis
To measure expression of other epithelial-derived cyto-
kines, the Proteome Profiler Human Cytokine Array
Kit, Panel A (R&D Systems) was utilized per the man-
ufacturer instructions. Cells were treated with TNF-a
in the presence or absence of apocynin, or untreated,
for 24 h and media was collected and incubated with
Figure 1 Structures of compounds investigated in this study. A
- Apocynin (Apo), B - 4-amino-2-methoxyphenol (Amino), C -2 -
methoxyhydroquinone (Hydroxyl), D - Guaiacol (Guai), E - 4-fluoro-2-
methoxyphenol (Fluoro), F - 4-hydroxy-3-methoxybenzonitrile
(Cyano), G - 4-methyl-2-methoxyphenol (Methyl), H - Diapocynin
(Diapo), I - Resveratrol (Res).
Table 1 Primers used in qPCR
Gene of Interest Primer
CCL5 - Forward 5’-TCCCCATATTCCTCGGACAC-3’
CCL5 - Reverse 5’-TGTACTCCCGAACCCATTTC-3’
MIF - Forward 5’-CCGGACAGGGTCTACATCA-3’
MIF - Reverse 5’-ATTTCTCCCCACCAGAAGGT-3’
IL-6 - Forward 5’-AGGAGACTTGCCTGGTGAAA-3’
IL-6 - Reverse 5’-CAGGGGTGGTTATTGCATCT-3’
CCL7 - Forward 5’-TGCTCAGCCAGTTGGGATTA-3’
CCL7 - Reverse 5’-GTCCTGGACCCACTTCTGTG-3’
IL-8 - Forward 5’-TAGCAAAATTGAGGCCAAGG-3’
IL-8 - Reverse 5’-AAACCAAGGCACAGTGGAAC-3’
Serpin E1 - Forward 5’-CTCTCTCTGCCCTCACCAAC-3’
Serpin E1 - Reverse 5’-GGAGAGGCTCTTGGTCTGAA-3’
CXCL1 - Forward 5’-CAAACCGAAGTCATAGCCAC-3’
CXCL1 - Reverse 5’-CTTCAGGAACAGCCACCAGT-3’
GMCSF - Forward 5’-GCTGCTGAGATGAATGAAACAG-3’
GMCSF - Reverse 5’-ACAGGAAGTTTCCGGGGTT-3’
CCL11 - Forward 5’-CCAGCTTCTGTCCCAACC-3’
CCL11 - Reverse 5’-AGTTTGGTCTTGAAGATCACAGC-3’
CCL2 - Forward 5’-GCTCAGCCAGATGCAATCA-3’
CCL2 - Reverse 5’-AGATCTCCTTGGCCACAATG-3’
CXCL10 - Forward 5’-CTGTACGCTGTACCTGCATCA-3’
CXCL10 - Reverse 5’-GGAGATCTTTTAGACCTTTCCTTG-3’
GAPDH - Forward 5’-GAGTCAACGGATTTGGTCGT-3’
GAPDH - Reverse 5’-TTGATTTTGGAGGGATCTCG-3’
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performed without deviation from the recommended
protocol. Membranes were treated with HyGlo chemi-
luminescence detection reagent (Denville Scientific,
Metuchen, NJ) and exposed to film to for various time
points to detect the signal. Films were scanned using a
Canon Lide 100 instrument and subjected to densito-
metric analysis with ImageJ software (http://rsb.info.
nih.gov/ij/). All experiments were carried out in
triplicate.
Reactive Oxygen Species (ROS) assay
Reactive oxygen species were detected with 3’,6’-diace-
tate-2’,7’-dichlorofluorescein (DCFH-DA) treatment. A 1
mM stock solution of DCFH-DA was prepared in
DMSO (Sigma), and added to cells were treated in cul-
ture medium at a final concentration of 10 μM. A549
or BEAS2B cell cultures were first treated with solvent
(No Tx - ethanol and H2O), TNF-a (50 ng/mL), or
TNF-a and 1 mM of Compounds A-C, H, and I (sepa-
rately) for 1 hour after the growth media was replaced
with fresh media. The cultures were then treated with
10 μM DCFH-DA or diluent for 1 h. DCFH-DA fluor-
esces only after internalization in cells and conversion
to 2’,7 ’-dichlorofluorescein which reacts with reactive
oxygen species to produce fluorescence [17]. The 6 well
plates in which the cells were grown are then placed in
the GENios plate reader and the fluorescence was
recorded (Ex - 485 nm; Em- 534 nm). The samples
were all run in triplicate and plotted against TNF-a
response.
Assay for NFB activation
A549 cell cultures were treated with diluent (1% etha-
nol and H2O), TNF-a (50 ng/mL), or TNF-a and 1
mM of apocynin for 1 hour. Cells were then harvested
via scraping and lysed with PLB (Polysomial Lysis
Buffer; 100 mM KCl, 5 mM MgCl2, 10 mM Hepes pH
7.0, 0.5% NP-40) for 10 minutes on ice. Isolation of
nuclear lysates was performed as previously described
[7]. The lysate was then loaded onto a 10% polyacryla-
m i d e - S D Sg e la n dr a na t4 5m Af o r1h o u r .T h e
protein was transferred via semi-dry transfer to a
nitrocellulose membrane. The membrane was probed
with a primary antibody for NFB/p65 (N-term),
NFB/p65 (Ser 311 phosphorylation) (Santa Cruz) and
b-tubulin (Abcam, Cambridge, MA) as a loading
control. The primary antibodies were recognized with
a secondary antibody specific for rabbit (Jackson
ImmunoResearch, West Grove, PA) after a 24 h incu-
bation in 3% BSA/TBS-T. The membrane was then
developed as described previously under the cytokine
array. The experiment was run in triplicate and
analyzed with ImageJ software.
Biotin-RNA affinity isolation assay
A549 cell cultures were treated with diluent (1% etha-
nol) or TNF-a (50 ng/mL) in the presence or absence
o f1m Mo fa p o c y n i n .A l lt r e a t m e n t sa r ef o r2 4h o u r s
except for apocynin treatment of lysed cells. In this
case, cells were treated for 24 h with TNF-a,l y s e d ,a n d
treated with apocynin for 30 min. After cellular lysis
with PLB, 1 μM of biotinylated CCL2 3’UTR RNA
(synthesized as previously described) was added to the
lysate for 30 minutes at room temperature in TENT
buffer (10 mM Tris (pH 8.0), 1 mM EDTA, 250 mM
NaCL, 1% v/v Triton X-100) and RNase Out [18]. The
mixture was then exposed to magnetic beads coated
with streptavidin (Dynabeads, Invitrogen) for 30 minutes
at room temperature. The beads were prepared per
manufacturer’s instructions. Unbound protein was
removed by washing three times with 250 μlo fP B S .
Protein was eluted with SDS-PAGE sample buffer (1 M
Tris pH 6.8, 40% glycerol, 10% SDS, 1%bromophenol
blue, H2O and 1 mM DTT) and then resolved on a 10%
polyacrylamide-SDS gel and developed as previously
described with a primary mouse antibody for HuR
(Santa Cruz Biotechnology) [7].
Statistical analysis
All experiments were performed in at least triplicate.
Data were analyzed using either Excel 2007 (Microsoft)
or GraphPad Prism 4.0. Values of significance (p ≤ 0.05)
were determined by non-parametric ANOVA testing
between treatment conditions and controls. Error bars
on all graphs represent the standard error of the mean.
Results
Anti-inflammatory effects of apocynin on human airway
cells
The respiratory epithelium is a major producer of cyto-
kines and other inflammatory mediators in a variety of
inflammatory lungs diseases [19]. As methoxyphenolic
compounds have demonstrated anti-inflammatory
effects, we sought to determine whether they attenuate
the production of inflammatory mediators in human air-
way cells. A549 human airway cells were treated with
TNF-a (50 ng/mL) to stimulate inflammatory mediator
production, and the effect of apocynin was assessed by
co-treatment with TNF-a with 1 mM apocynin (Com-
pound A, Figure 1) for 24 hours. Expression of a panel
of epithelial-derived cytokines known to be induced by
TNF-a (Figure 2A) was assessed by qPCR. The ability of
apocynin to inhibit the TNF-a stimulation of each cyto-
kine is shown in Figure 2A as the ratio of the fold
increase for each cytokine under Apocynin/TNF-a treat-
ment compared to TNF-a treatment alone. Apocynin
significantly attenuated the expression (p < 0.05, n = 3)
of all of the cytokines measured by at least 50%, except
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greatest effect was seen on GMCSF, CXCL10, and CCL2
where there was a 90% reduction in the level of TNF-a-
induced mRNA production. Effects of apocynin on
TNF-a-induced cytokine production was also measured
in BEAS2B cells (Figure 2B) and normal human primary
bronchial epithelial cells (PBECs, Figure 2C) to ensure
that the results were not cell line specific. Apocynin
exerted a similar anti-inflammatory effect, and a similar
inhibitory effect was observed on the gene expression of
numerous inflammatory mediators (IL-6, IL-8, CCL2,
CXCL1, MIF, and Serpin E1).
As levels of mRNA and protein do not always
correlate, and because many of these cytokines are post-
transcriptionally regulated, we monitored the effect of
apocynin on the protein levels of these cytokines [20].
A549 cells were treated as described above and secreted
cytokine expression was analyzed by a combination of
ELISAs and a cytokine array. Figure 2D depicts a repre-
sentative image of the raw cytokine array data, with
changes in IL-6, IL-8, ICAM-1, and CXCL1 shown
between TNF-a and apocynin/TNF-a treatment. Densi-
tomteric analysis was performed with ImageJ software
and summarized in Figure 2E. For cytokines not present
on the array, or in cases where the array failed to detect
any cytokine production after TNF-a treatment, ELISAs
were performed. Apocynin treatment leads to an almost
complete loss of signal for ICAM-1 and IL-6, and a sta-
tistically significant (p < 0.05) inhibition of all other
cytokines measured. CCL11 and GM-CSF expression
could not be detected by either array or ELISA, indicat-
ing that these cytokines are poorly expressed in these
cells after TNF-a treatment. Interesting, apocynin also
inhibited the production of CCL5 protein, despite not
having an effect on its mRNA level, suggesting that
there is a post-transcriptional mechanistic component of
the drug. Along the same lines, there was approximately
a 50% change in IL-6 mRNA level with apocynin-treat-
ment, but an almost complete inhibition in protein
expression. For other cytokines (i.e. CCL2, IL-8) the
change in protein and mRNA levels correlated well. We
also measured the ability of apocynin to inhibit CCL2
Figure 2 Effects of apocynin on cytokine mRNA and protein levels under inflammatory conditions. A, Real time PCR data gathered from
mRNA isolated from A549 cells treated with TNF-a (50 ng/ml) in the presence of absence of Apocynin (Apo, 1 mM) for 24 h. Shown are relative
levels of inflammatory mediator mRNA in the Apo/TNF-a vs. TNF-a treatment (n = 3; *,p < 0.05; NS, not statistically significant. Cytokine gene
expression changes were also measured in BEAS2B cells (B) and PBECs (C), D,Representative raw data from the protein array experiment,
comparing cytokine levels in the Apo/TNF-a vs. TNF-a treatment. E, ELISA and densitometeric analysis of cytokine protein array data, comparing
cytokine levels in the Apo/TNF-a vs. TNF-a treatment (n = 3; *, p < 0.05; ND, not detected). F, CCL2 expression was measured by ELISA in A549
cells, BEAS2B cells, and PBECs under the treatment conditions described above.
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PBEC cells. Both cell types demonstrated similar effects
as A549 cells (Figure 2F).
Kinetics of apocynin effect on TNF-a-induced cytokine
production
To determine the time course of apocynin inhibition on
TNF-a-induced cytokine production, a kinetic assess-
ment was performed at various time points. The greatest
effects of TNF-a on CCL2 mRNA production begins
between 1.5 and 3 h and peaks at 12 h (Figure 3A). The
inhibitory effects of apocynin begin between 1.5 and 3 h
and continue for 24 h. A similar effect is noted for
CCL2 protein production. At 3 hours apocynin has
begun to inhibit CCL2 protein production, and the
effect is maintained at 24 hours levels (Figure 3B).
Comparison of the anti-inflammatory effects of apocynin
and diapocynin
We previously demonstrated that apocynin forms a
dimer (Figure 1H) under oxidative conditions, and this
dimer was the active form of the drug [8]. Dimerization
required the presence of H2O2 and a peroxidase (such
as myeloperoxidase), and these enzymes are not
expressed in airway epithelial cells [21]. It is possible
that under inflammatory conditions in vivo, phagocytic
myeloperoxidases could induce dimerization of the drug,
which could then be taken up by epithelial cells. How-
e v e r ,i ti sa l s op o s s i b l et h a tt h em e c h a n i s mo fa c t i o ni s
different in the airway, and the monomer is active. To
determine whether the apocynin monomer or dimer is
the active form in airway epithelial cells, we analyzed
the effect of apocynin in the presence or absence of
H2O2 and horseradish peroxidase and diapocynin on
CCL2 production in TNF-a treated cells.
By ELISA, CCL2 levels were unaffected by H2O2,
HRP, and the combination of the two (Figure 4A). TNF-
a treatment resulted in a 36 ± 6.5 fold increase in
the amount of secreted CCL2 protein after 24 hours
(p < 0.05, n = 3). Apocynin effectively prevented CCL2
production, reducing the levels to that of the no treat-
ment control (p < 0.05, n = 3). Apocynin treatment in
t h ep r e s e n c eo fH 2O2 and HRP similarly reduced CCL2
production. Diapocynin (1 mM) was the best inhibitor
of CCL2, reducing levels to a point below the baseline
level in unstimulated cells. The addition of HRP, H2O2,
or the combination of the two had no effect on CCL2
level.
These data suggest that apocynin monomer also has
anti-inflammatory activity, independent of the presence
of HRP and H2O2. However, as there could be a differ-
ence in potency between the monomer and dimer, we
measured the inhibitory effect on CCL2 production as a
function of the concentration of each compound. A
concentration-dependent effect was seen for the apocy-
nin in the presence and absence of ROS and diapocynin
(Figure 4B), without any toxicity to the cells observed at
the highest concentration (10 mM). The following IC50
values for calculated each compound: 20.3 ± 3.8 μM
for diapocynin, 103.4 ± 13.6 μM for apocynin with
H2O2 and HRP, and 146.1 ± 5.2 μM for apocynin alone
(Table 2). We also measured the IC50 for apocynin in
BEAS2B cells, which 275 ± 5 μM, similar to that
obtained for A549 cells (Figure 4C).
Anti-inflammatory effects of other methoxyphenols
in human airway cells
In order to determine whether other methoxyphenols
may also exhibit anti-inflammatory effects on human
airway cells, the effects of various 4-substituted com-
pounds and resveratrol were analyzed. As a screen, the
Figure 3 Time course of apocynin effects on CCL2 protein and
mRNA levels. A, CCL2 mRNA levels by real time PCR for TNF-a
or TNF-a/Apocynin treatment in A549 cells for the indicated time
(n = 3). B, The effect of apocynin treatment on CCL2 protein levels
for the indicated times after treatment with TNF-a or TNF-a/
Apocynin (n = 3).
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TNF-a induced production of CCL2 was measured.
Similar to previous experiments, apocynin shows a sig-
nificant (p < 0.05, n = 3) reduction in amount of protein
produced (Figure 5A). Compounds D, E, G show little
effect on the amount of CCL2 protein produced while
compounds B and C and I show an effect equal to or
greater than apocynin (p < 0.05). For the latter com-
pounds, varying concentrations were used to obtain a
dose response curve for CCL2 production. Resveratrol
Figure 4 Effect of apocynin and diapocynin on CCL2. A,e f f e c t s
of various treatments on CCL2 production: H2O2, HRP, H2O2 + HRP
(HH), TNF-a, apocynin (Apo), diapocynin (Diapo). All experiments
were performed in triplicate; *, p < 0.05 when compared no
treatment; †, p < 0.05 when compared to TNF-a treatment; NS, not
statistically significant. B, concentration-response curve of
diapocynin and apocynin in the presence or absence of H2O2 +
HRP on CCL2 protein levels (n = 3). C, concentration dependence of
apocynin on CCL2 production was measured in BEAS2B cells and
compared to effects in A549 cells.
Table 2 Comparison of IC50 Values For Selected
Compounds
Anti-Inflammatory Compound IC50 (μM)
Apocynin (A) 146.1 ± 5.2
Apocynin (A) with H2O2 and HRP 103.4 ± 13.6
Diapocynin (H) 20.3 ± 3.8
Resveratrol (I) 42.7 ± 1.8
Amino (B) 410.0 ± 77.2
Hydroxyl (C) 64.3 ± 9.5
Figure 5 Anti-inflammatory effect of compounds on CCL2
production. A, effect of 4-substituted methoxyphenolic compounds
and resveratrol (Res) on TNF-a induced CCL2 production (n = 3; *, p
< 0.05 when compared no treatment; †, p < 0.05 when compared
to TNF; NS, not significant). B,dose-response curves of various
compounds on CCL2 production (n = 3).
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by the hydroxyl derivative (Compound C) of 64.3 μM
(Table 2). Both of those compounds have IC50 values
lower than apocynin but higher than diapocynin. The
amino derivative (Compound B) had the highest IC50,
410.9 μM.
Mechanism of apocynin action
Apocynin was previously shown to inhibit production of
ROS, either as an anti-oxidant and/or as an inhibitor of
the p47phox component of NADPH oxidase complexes
[22]. To determine whether apocynin inhibited ROS
production, a fluorescent assay was utilized to quantita-
tively measure levels. Human airway cells (A549),
untreated or treated with TNF-a (50 ng/ml) in the pre-
sence or absence of 1 mM of the compound, were then
mixed with DCFH-DA (10 μM) for 1 h. Unexpectedly,
DCFH-DA appeared to be toxic to the A549 cells, and
approximately 50% of the cells were no-longer adherent
to the tissue culture plate after 1 h. Fluorescence was
monitored in these cells and the values are shown as a
r a t i or e l a t i v et oT N F - a treatment in Figure 6A. No
difference was noted in ROS levels in any of the treat-
ments, though it was not clear of these results were arti-
factual given the effect of DCFH-DA on the cells. We
then repeated the experiment in BEAS2B cells (Figure
6B). In these cells, DCHF-DA did not appear to be
toxic, and as expected, TNF-a induces ROS generation
relative to the untreated cells. The hydroxyl and amino
compounds significantly attenuated the ROS production,
however, apocynin, diapocynin, and resveratrol had no
effect on the levels. These data indicate that the inhibi-
tory effect of these compounds on cytokine production
does not correlate with their ability to reduce generation
of ROS.
As most of the cytokines inhibited by apocynin are
regulated by NF-B, it is possible that the compounds
might directly target the transcription factor. Apocynin
has been proposed to oxidize proteins to alter
phosphorylation or translocation, which are essential for
NF-B function [23,24]. The activation of NF-Bi n
A549 cells was assessed by phosphorylation at Ser311
and translocation to the nucleus after TNF-a treatment
in the presence or absence of apocynin (1 mM). As
expected, TNF-a stimulation induced the phosphoryla-
tion of NF-B as well as its translocation to the nucleus
(Figure 6C). However, apocynin had no effect on either
process, indicating that it does not inhibit NF-B.
We previously demonstrated that TNF-a treatment
led to the HuR-mediated mRNA stabilization of a num-
ber of prominent airway epithelial-derived cytokines and
chemokines [7]. Post-transcriptional regulation is emer-
ging as a central mechanism in controlling an inflamma-
tory response, and as such we investigated the effects of
apocynin on binding of HuR to CCL2. We previously
demonstrated that HuR binds to the 3’UTR of CCL2
transcript, stabilizing the cytokine mRNA and increasing
its expression [7]. HuR is expressed at baseline in A549
cells, and treatment with TNF-a i nt h ep r e s e n c eo r
absence of apocynin did not significantly alter cytoplas-
mic HuR expression (Figure 7A, B). Association of HuR
with the CCL2 3’UTR was assessed using a biotinylated
Figure 6 Effect of compounds on ROS production and NF-B
activation. DCFH-DA fluorescence assay various compounds after a
1 h treatment with TNF-a or TNF-a/Compound (1 mM). (*, p < 0.05
of TNF-a/compound vs TNF-a) in A549 (A) or BEAS2B (B) cells. C,
effect of TNF-a or TNF-a/Apocynin on expression, phosphorylation
(at Ser311), or nuclear translocation of NF-B. Data shown is
representative of n = 3.
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ted with TNF-a in the presence or absence of apocynin)
were lysed, mixed with biotinylated RNA, and RNA-pro-
tein complexes were isolated using magnetic streptavidin
beads. Eluted protein was analyzed by Western blot,
which demonstrated that apocynin treatment inhibited
the binding of HuR (Figure 7C, D) [7]. If TNF-a-treated
cells were lysed, then treated with apocynin, no effect
on HuR binding was observed, indicating the effects of
the drug required the presence of intact cells.
Discussion
The airway epithelium plays a central role in the initia-
tion and propagation of the inflammatory response. In
response to inflammatory stimuli such as cytokines,
airway epithelial cells produce large amounts of cyto-
kines, chemokines and other inflammatory mediators.
We investigated the anti-inflammatory effects and
mechanisms of action of several 4-substituted methoxy-
phenols and resveratrol on TNF-a-stimulated human
airway cells. The significance of these findings is dis-
cussed herein.
Apocynin attenuate the inflammatory effects of TNF-a
in airway epithelial cells
We and others have previously demonstrated that apoc-
ynin and other 4-substituted methoxyphenols have anti-
inflammatory properties in endothelial cells as well as
phagocytes, implicating them as potential therapeutic
agents in vascular diseases [8,10]. Their effects on airway
epithelial cells have not been characterized, however,
even though apocynin has been used as a traditional
anti-asthma agent, and there are multiple animal studies
demonstrating anti-inflammatory effects in asthma
[21,25]. Using a TNF-a-stimulated model of human air-
way epithelial cells, we demonstrated that apocynin atte-
nuated the production of numerous important
epithelial-derived cytokines and chemokines. For the
majority of the cytokines investigated, apocynin signifi-
cantly reduced their production by more than 50%. For
some mediators, such as IL-6, CXCL10, and ICAM-1,
apocynin treatment led to almost undetectable levels.
Inhibition of IL-6, an inflammatory cytokine with wide-
spread actions, would be expected to produce anti-
inflammatory effects in a wide variety of settings.
Furthermore, the CC chemokines (i.e. CCL2, CCL5)
play key roles in the recruitment of monocytes, dendritic
cells, and T-cells, while CXC chemokines (CXCL1,
CXCL10, IL-8) are important neutrophil recruiters [26].
The cell adhesion molecule ICAM-1 also plays a key
role in migration of leukocytes, and together these data
indicate that apocynin would be effective in inhibiting
the trafficking of leukocyotes to sites of inflammation.
The concentration-dependence of apocynin on cyto-
kine production was demonstrated for the inhibition
CCL2. This was chosen as a model cytokine as it is
highly expressed in the respiratory epithelium, is an
important chemoattractant for monocytes, dendritic
cells, T-cells, and basophils [27], and is significantly
attenuated by apocynin treatment. Apocynin was found
to have a concentration-dependent effect, and an IC50
value of 146 μM was calculated. Though this value was
Figure 7 Effect of apocynin on HuR binding to CCL2 RNA. A,
HuR expression was monitored by Western blot under various
treatment conditions: unstimulated, treatment of cells with TNF-a or
TNF-a/apo for 24 h. Data is a representative blot of n = 3. B,
Quantitation of HuR protein level after various treatments relative to
unstimulated cells by densitometry, using b-tubulin as a loading
control for normalization. C,binding of HuR to CCL2 3’UTR by biotin
affinity isolation. Lysates were incubated with biotinyated CCL2
3’UTR RNA, mixed with streptavidin beads, washed, and isolated
proteins were analyzed by Western blot to identify HuR binding.
TNF,Apo’, cells were treated with TNF-a for 24 hours, lysed and then
treated with apocynin (1 mM) for 30 min. Blot of representative
data of n = 4. Each lane was taken from the same exposure of the
same Western blot and re-arranged in order for the figure (L- pure
lysate, PD- lysate after treatment with beads and biotinylated RNA).
D, Densitometeric analysis of the Western blot data. (*, p < 0.05
when compared to TNF:No Tx Ratio), n = 4).
Houser et al. Journal of Inflammation 2012, 9:6
http://www.journal-inflammation.com/content/9/1/6
Page 9 of 12somewhat high, apocynin has been shown to have an
excellent safety profile in rodents, with an LD50 of 9 g/
kg, and we observed no toxic effects on our cells even
at concentrations of 10 mM [9]. These findings were
echoed in a phase I human study, where 6 ml of a 0.5
mg/mL of apocynin was nebulized into the airway of
normal subjects without any adverse effects [28].
Effects of other 4-substituted methoyphenols and
resveratrol
To identify more potent anti-inflammatory compounds,
we measured the effects of other 4-substituted methoxy-
phenols and the related compound resveratrol on pro-
duction of inflammatory mediators. In general, we
found that compounds with more electron withdrawing
groups were more likely to have anti-inflammatory
effects. Of the compounds tested, the hydroxyl-substi-
t u t e dc o m p o u n d( c o m p o u n dC )h a dt h el o w e s tI C 50 of
the monomeric compounds tested. As the apocynin
dimer was the most potent compound, it is possible that
the dimer of the hydroxyl-substituted compound would
also have enhanced activity relative to the monomer,
and this might be explored as strategy to produce a
more potent anti-inflammatory agent. Resveratrol is a
closely related compound that has been suggested to
have benefit in a wide variety of diseases, including
inflammatory diseases [29]. In this study, it behaved
similarly to the methoxyphenols, and had potency simi-
lar to diapocynin. These data demonstrate that resvera-
trol has anti-inflammatory properties in human airway
cells supports its therapeutic potential in treatment of
asthma and COPD. Somewhat surprisingly, the fluori-
nated compound (compound E) showed no anti-inflam-
matory activity, despite having better efficacy over
apocynin in inhibiting ROS production in neutrophils
and mononuclear leukocytes [10]. This suggests that the
mechanism of action of apocynin in epithelial cells is
distinct from its action in leukocytes, and this concept is
explored in more detail below.
Is diapocynin the active form of the compound?
Previously, we showed that apocynin forms a dimer in
the presence of reactive oxygen species and peroxidase,
and that the dimer was the active form of the drug
[8,30]. In phagocytes, apocynin is taken up by the cell
and converted to the dimeric form in the presence of
ROS and myeloperoxidase [30,31]. To investigate the
activity of the monomer and dimer, we treated TNF-a-
challenged cells with apocynin, apocynin in the presence
of ROS and exogenous peroxidase, and diapocynin. Dia-
pocynin was found to have the lowest IC50, followed by
apocynin plus ROS and peroxidase, then apocynin
alone. As peroxidases are not known to be expressed in
epithelial cells, these data indicate that the monomer
does have activity, though the dimer is more potent.
The intermediate potency of the apocynin/ROS/peroxi-
dase mix suggests that some dimer is formed under
these conditions, and thus the effects seen may be due
to a mix of monomer, dimer.
Mechanism of action of apocynin in the airway
epithelium
The observation that the apocynin monomer has activity
independent of the dimer in airway epithelial cells sug-
gests that it may act via a different mechanism of action
than in phagocytes and endothelium. Apocynin has
been proposed to inhibit ROS production by inhibiting
the NADPH oxidase complex, or by acting as a free
radical scavenger. Preventing formation of ROS genera-
tion may have anti-inflammatory effects via a variety of
mechanisms, including the activation of important tran-
scription factors such as NF-kB as previously reported
[32]. In our system, we observed no correlation between
ROS inhibition and anti-inflammatory activity. It should
be noted that we did not specifically measure mitochon-
drial ROS generation, and it is not known if apocynin
might inhibit this pathway specifically.
Apocynin treatment did not affect phosphorylation
and translocation of the NF-B transcription factor, sug-
gesting that its anti-inflammatory effects were not due
to effects on this transcription factor in epithelial cells.
However, as nuclear translocation and Ser311 phosphor-
ylation are not the only markers of NF-Ba c t i v i t y ,w e
cannot completely exclude exclude that apocynin has
effects on NF-B activity or other transcription factors,
and this will require further study.
The effect of TNF-a and other inflammatory media-
tors on gene regulation in epithelial cells is complex,
and involves changes on the level of transcription as
well as post-transcriptional effects. Post-transcriptional
regulation is emerging as a crucial control point in the
regulation of the inflammatory response, and most often
involves changes on mRNA stability or translation.
RNA-binding proteins, such as HuR, bind to AU-rich
regions and other regulatory elements in the 3’UTR of
inflammatory transcripts and promote mRNA stability
or affect translation [33]. We previously demonstrated
that TNF-a stimulation led to post-transcriptional up-
regulation of many cytokines and chemokines, mediated
by HuR stabilization of transcripts [7]. As shown in
Figure 7C, D, apocynin inhibited the binding of HuR to
C C L 2R N A ,s u g g e s t i n gt h a ta tl e a s ts o m eo fi t se f f e c t s
may be post-transcriptional in nature. As many of the
other cytokines that apocynin repressed (i.e. IL-6, IL-8,
CXCL1) are targets of HuR, a loss of HuR effect may
also underlie these effects [7], We also observed that
the effects of apocynin on mRNA and protein levels did
not always correlate, supporting a role in post-
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http://www.journal-inflammation.com/content/9/1/6
Page 10 of 12transcriptional regulation. The molecular mechanisms of
apocynin are not clear. Apocynin may act to oxidize
cysteine residues on proteins to alter structure or post-
translational modifications [10]. The effect on HuR
binding required treatment of intact cells rather than a
cell lysate, indicating that apocynin is not simply bind-
ing to the protein. It is possible that the drug acts
upstream of HuR, such as on kinases or phosphatases
that regulate HuR, or may act on other RNA-binding
proteins that compete with HuR for mRNA-binding.
HuR has been reported to be phosphorylated by a num-
ber of kinases, including Chk2, Cdk1, p38, PKCa and
PKC δ [34]. In particular, Chk2, p38, and PKC’sh a v e
been shown to affect binding to mRNA, and could be
affected by apocynin. Future work will be aimed at
determining the effects of apocynin on HuR and its
overall effects on transcription and post-transcriptional
control.
Conclusions
Methoxyphenols represent a class of novel anti-inflam-
matory compounds that may have therapeutic implica-
tions in a variety of inflammatory diseases by acting on
the epithelium as well as leukocytes.
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